ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 904

Clinical Features and Mortality of 411 Chinese Takayasu’s Arteritis Patients

Jing Li1, Fei SUN1, Yunjiao Yang1, Mengtao Li2, Xinping TIAN1 and Xiaofeng Zeng3, 1Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Beijing, China, 2Rheumatology, Peking Union Medical College Hospital, Beijing, China, 3Department of Rheumatology and Immunology, Peking Union Medical College Hospital, Beijing, China

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Angiography, Takayasu.s arteritis and death

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2016

Title: Vasculitis - Poster I: Large Vessel Vasculitis and Polymyalgia Rheumatica

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: To investigate the clinical features and long-term outcome of Chinese Takayasu arteritis (TAK) patients.

Methods: Medical records of 411 Chinese TAK in-patients (325 female, 86 male) who fulfilled 1990 ACR classification criteria during 1990 to 2014 were retrospectively reviewed. Clinical manifestations, angiographic presentations, and causes of death were collected and analyzed.

Results: The median age at disease-onset was 23(18, 30) years old, and the median disease duration was 21(6, 60) months. Aortic aneurysm, renal dysfunction, and heart failure were more likely to be found in patients with heart involvement, while weight loss and arthralgia were more likely occur in patients without. Pulse deficit were more likely to be found in patients with cerebral artery involvement, while pericarditis, ischemic heart disease, and fever were more likely occur in patients without. No difference were found in patients with and without renal, or pulmonary arteries involvement (See Table 1). Subclavian(79%), carotid(64%), abdominal aorta(38%), vertebral(29%), mesenteric(28%), thoracic aorta(21%), innominate(20%), iliacofemoral(11%), ascending aorta(10%), and aortic arch(8%) were most commonly involved. Stenosis (93%) and occlusion (59%) were much more common than dilation (20%) and aneurysm (6%) (Table 2). Analysis of 10 deceased patients found heart failure (42%), hemorrhage (17%), and pulmonary infection (17%) were the top 3 direct causes of death, and congestive heart failure, secondary hypertension, and long disease duration were risk factors for poor prognosis in TAK (Table 3).

Conclusion: The clinical manifestations, blood vessel involvement, and angiographic presentations in Chinese TAK patients are different from reports in the literature. Heart failure is the leading cause of death in these patients and are the risk factor of poor prognosis.


Disclosure: J. Li, None; F. SUN, None; Y. Yang, None; M. Li, None; X. TIAN, None; X. Zeng, None.

To cite this abstract in AMA style:

Li J, SUN F, Yang Y, Li M, TIAN X, Zeng X. Clinical Features and Mortality of 411 Chinese Takayasu’s Arteritis Patients [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/clinical-features-and-mortality-of-411-chinese-takayasus-arteritis-patients/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clinical-features-and-mortality-of-411-chinese-takayasus-arteritis-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology